LIVER CANCER (LOCALLY ADVANCED OR METASTATIC)
Clinical trials for LIVER CANCER (LOCALLY ADVANCED OR METASTATIC) explained in plain language.
Never miss a new study
Get alerted when new LIVER CANCER (LOCALLY ADVANCED OR METASTATIC) trials appear
Sign up with your email to follow new studies for LIVER CANCER (LOCALLY ADVANCED OR METASTATIC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo could supercharge liver cancer radiation
Disease control Recruiting nowThis study tests whether a short infusion of angiotensin II, given directly into the liver artery, can help radioactive beads reach liver tumors more effectively while sparing healthy tissue. About 15 adults with liver cancer will receive the drug right before standard radioembol…
Matched conditions: LIVER CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE2 • Sponsor: Niek Wijnen • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New shot SH009 targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called SH009 in people with advanced solid tumors (like liver, lung, breast, or stomach cancer) that have not responded to standard treatments. The main goals are to see if the drug shrinks tumors and to check its safety. About 150 adults w…
Matched conditions: LIVER CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1 • Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC